All Press Releases

PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer

View full press release on Businesswire. PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and to...

Utah-based PhotoPharmics Selected as Global Top 50 Startup

Utah-based PhotoPharmics Selected as Global Top 50 Startup MedTech Innovations designates PhotoPharmics as one of the industry’s best and brightest startups working to transform patient care through innovation June 24, 2021. Salt Lake City—PhotoPharmics today...

PhotoPharmics Innovations Address Global Health Inequalities

​PhotoPharmics Innovations Address Global Health Inequalities Utah-based Life Sciences Company to Combine Breakthrough Designation and MCIT to Provide At-home Access for the Treatment of Neurodegenerative Diseases April 12, 2021, Salt Lake City, UT -- Innovation not...

Phase 3 Trial Aims to Establish Non-Motor Improvement in Parkinson’s

Phase 3 Trial Aims to Establish Non-Motor Improvement in Parkinson’s PhotoPharmics and University of Rochester to Collaborate on Stay-At-Home Trial July 14, 2020, Salt Lake City, UT— PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative diseases,...

Largest Phototherapy Trial for Parkinson’s Disease

View the full release on EIN Newswire Largest Phototherapy Trial for Parkinson’s Disease PhotoPharmics Finalizing Pivotal Phase 3-Equivalent Trial for Improving Overall Function February 10, 2020, Salt Lake City, UT— PhotoPharmics announced today plans to conduct a...

PhotoPharmics Submits FDA Application for Parkinson’s Disease Therapy

PhotoPharmics Submits FDA Application for Parkinson’s Disease Therapy 510K De Novo Pathway Key to Market Authorization for Company’s Innovative Medical Device July 16, 2018, Salt Lake City, UT— PhotoPharmics announced today that its De Novo request to the FDA has been...

Media Contact

Brett Walker
801.770.6960
brett.walker@photopharmics.com